Our most recent INAS-SCORE publication has been selected as a ‘highlighted’ article for this month’s edition of the European Journal of Contraception and Reproductive Health. The article will be freely available to download next month (August 2019), via this link: ... Read More
News/Conferences
Unintended pregnancy rates differ according to combined oral contraceptive – results from the INAS-SCORE study.
Yesterday, our latest publication, Unintended pregnancy rates differ according to combined oral contraceptive – results from the INAS-SCORE study was published online in the European Journal of Contraception and Reproductive Health Care. The study was aimed at estimating the real-use ... Read More
Real world data on Nexplanon® procedure-related events: final results from the Nexplanon observational risk assessment study (NORA)
Our latest publication, Real-world data on Nexplanon® procedure-related events: final results from the Nexplanon observational risk assessment study (NORA) has just been published in Contraception. The study was aimed to characterize the frequency of insertion-, localization- and ... Read More
Eight abstracts have been accepted at the FIGO XXII RIO World Congress of Gynecology and Obstretrics
Congratulations to our Project Management team! This October 2018 they will be headed to Rio de Janeiro, Brazil to present at the FIGO XXII RIO World Congress of Gynecology and Obstetrics. We are proud to announce that eight of our abstracts were accepted; seven oral presentations and one poster for ... Read More
New privacy rules
With a view to the introduction of the GDPR/EUDSGVO we are glad to present our new updated privacy rules. The updated descriptions are stored under "about us" and then "privacy policy/GDPR". Further translation for study participants will follow. ... Read More
Seven abstracts accepted for ESC Budapest
Congratulations to our Project Management team! In May 2018 they will be headed to Budapest to present at the European Society of Contraception. This year we are proud to announce that seven of our abstracts were accepted; two oral presentations and five posters - three with presentations during ... Read More
We’re Hiring!
ZEG Berlin is growing... we are currently searching for analytical-minded, people with strong ethics and an interest in medical research to join our vibrant Berlin-based team. At ZEG Berlin we help pharmaceutical companies answer complex drug safety questions and stay abreast of an ever-changing ... Read More
Final results of from the EURAS-IUD extension study
Our latest publication, Perforation risk and intra-uterine devices: results of the EURAS-IUD 5-year extension study, has just been published in the European Journal of Contraception and Reproductive Health Care. This landmark observational study followed women for 5 years and identified ... Read More
Meet us at ICPE
We are delighted to be packing our bags again this summer and heading across the Atlantic to the International Society of Pharmacoepidemiology (ISPE) conference in Montreal, Canada. Our project management team will be presenting five posters and one oral presentation over the five days sharing the ... Read More
Join us at the 33rd International Conference on Pharmacoepidemiology and Clinical research
Join ZEG Berlin at the 33rd International Conference on Pharmacoepidemiology and Clinical research in August, 2017. We will have oral and poster presentations on our latest studies. Last year ZEG presented two oral presentations and three poster presentations. This year is set to be no ... Read More
Fertility and oral contraceptives
Our latest publication, Fertility and combined oral contraceptives - unintended pregnancies and planned pregnancies following oral contraceptive use - results from the INAS-SCORE study, was published in the European Journal of Contraception and Reproductive Health in October 2016. In this article we ... Read More
updated